CME vs. Nu: Which Financial Stock Is a Better Buy for 2027?
CME boasts a 62% net margin and fortress balance sheet, while Nu's 43% revenue growth signals emerging-market momentum, but their risk profiles diverge sharply.
Full story
Read the full story at The Motley Fool ↗
Continue reading this story on The Motley Fool, the publisher that reported it.
AI tools
Written by AI from the article text. It can make mistakes; check the original story.
